How Quantum Computers Are Designing Better Antibiotics

In this episode, Lucas and Luna explore how quantum computing is being used to design new antibiotics by simulating molecular interactions that classical computers can't handle. They focus on a specific case: a 2025 collaboration between IBM Quantum and a major pharmaceutical company that used a 127-qubit processor to model the binding affinity of a novel antibiotic candidate against drug-resistant E. coli. The simulation reduced the initial screening process from 18 months to just 3 weeks, identifying a promising compound that is now in preclinical trials. The hosts explain why quantum chemistry matters for drug discovery, how error mitigation techniques made this possible, and why this approach could shift the economics of antibiotic development — a field where big pharma has historically underinvested due to low profit margins. They also touch on the broader implications for antimicrobial resistance, which the WHO calls one of the top global health threats. #QuantumComputing #Antibiotics #DrugDiscovery #IBMQuantum #QuantumChemistry #AntimicrobialResistance #ErrorMitigation #Qubits #MolecularSimulation #Pharmaceuticals #DrugResistantEcoli #Technology #QuantumHardware #PreclinicalTrials #HealthTech #FexingoBusiness #BusinessPodcast #FutureComputing Keep every episode free: buymeacoffee.com/fexingo